Page last updated: 2024-11-01

nu2058 and Neoplasms

nu2058 has been researched along with Neoplasms in 1 studies

NU2058: structure in first source

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tadesse, S1
Caldon, EC1
Tilley, W1
Wang, S1

Reviews

1 review available for nu2058 and Neoplasms

ArticleYear
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update.
    Journal of medicinal chemistry, 2019, 05-09, Volume: 62, Issue:9

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Cyclin-Dependent Kinase 2; Drug Design; Hu

2019